NHC
National HealthCare Corporation
NYSE AmericanUSDEQUITY
Healthcare
DELAYED
Buy
+47/100
Last price
228.27
▼ 2.10 (0.91%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
231.31
Prev close
230.37
Day high
231.94
Day low
227.37
Volume
90.58K
Market cap
$3.58B
P/E (TTM)
25.68
52W range
116.42 – 239.29
Day trading desk
Gap from prior close
+0.41%
Prior close 230.37
VWAP
228.49
-0.10% from price
Relative volume
1.47×
Normal
Session range
2.06%
227.26 – 231.94
Position in range
22%
Near session low
ATR (14D)
5.87
2.57% of price
Prior day high
232.17
PDH
Prior day low
223.40
PDL
Bid / ask spread
—
Quote not published
Session volume
160.30K
Avg 108.73K
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
+1.83%
-0.1%
1M
+4.40%
+3.2%
3M
+7.79%
+3.3%
6M
+37.17%
+19.0%
YTD
+66.51%
+52.3%
1Y
+88.16%
+71.7%
3Y
+256.78%
+174.5%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on NHC open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
+15.85K
Net buying
Buy transactions
15
57.35K shares
Sell transactions
10
41.50K shares
Net transactions
+25
Buys less sells
Sell : buy shares
0.7 : 1
Mixed
Insider-held shares
2.95M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Sep 22, 26 | DODSON VICKI L Officer |
SELL | 4.83K | $1.09M | Direct |
| Sep 11, 26 | KIDD BRIAN F. Officer |
SELL | 6.81K | $1.54M | Direct |
| Sep 10, 26 | MCCREARY JOSH A General Counsel |
SELL | 2.72K | $609.67K | Direct |
| Aug 28, 26 | FLATT BEN ANDERSON SR Chief Technology Officer |
SELL | 7.00K | $1.59M | Direct |
| Aug 25, 26 | GIFFORD DAVID M.D. Director |
SELL | 1.78K | $401.02K | Direct |
| Aug 20, 26 | GIFFORD DAVID M.D. Director |
CONVERSION | 6.48K | $1.11M | Direct |
| Aug 19, 26 | FLATT STEPHEN FOWLER Officer and Director |
SELL | 1.50K | $355.62K | Direct |
| Aug 13, 26 | GIFFORD DAVID M.D. Director |
CONVERSION | 1.02K | $175.02K | Direct |
| Jun 22, 26 | HASSAN EMIL E Director |
SELL | 5.94K | $1.19M | Direct |
| Jun 16, 26 | HASSAN EMIL E Director |
SELL | 1.56K | $312.56K | Direct |
| Jun 16, 26 | KIDD BRIAN F. Chief Financial Officer |
STOCK | 500 | $0 | Direct |
| Jun 8, 26 | ADAMS ROBERT G. Director |
CONVERSION | 4.00K | $276.76K | Indirect |
| Jun 8, 26 | ADAMS ROBERT G. Director |
STOCK | 4.00K | $0 | Indirect |
| Jun 1, 26 | PIERCEY LISA M.D. Director |
BUY | 949 | $174.86K | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
ABERNATHY JAMES PAUL |
Director | 43.30K | Conversion of Exercise of derivative security |
ADAMS ROBERT G. |
Director | — | Conversion of Exercise of derivative security |
ADAMS W ANDREW |
Director | 704.91K | Conversion of Exercise of derivative security |
FLATT BEN ANDERSON SR |
Chief Technology Officer | 15.64K | Sale |
FLATT STEPHEN FOWLER |
Officer and Director | 65.49K | Sale |
HASSAN EMIL E |
Director | 65.59K | Sale |
KIDD BRIAN F. |
Officer | 23.18K | Sale |
LAROCHE RICHARD F JR |
Director | 205.76K | Sale |
NATIONAL HEALTH CORP |
Affiliated Person | 1.03M | Sale |
USSERY ROBERT MICHAEL |
President | 160.52K | Stock Gift |
Fundamentals
Market cap$3.58B
Enterprise value$3.40B
Revenue (TTM)$1.56B
Gross profit$615.63M
EBITDA$190.40M
Net income$140.26M
EPS (TTM)$8.89
Free cash flow$63.17M
Total cash$210.19M
Total debt$31.41M
Book value / share$71.66
Shares outstanding15.66M
Float12.71M
Short % of float5.38%
Dividend yield1.17%
Beta (5Y)0.61
Valuation & profitability ratios
Trailing P/E25.68
Forward P/E530.86
PEG ratio0.82
Price / sales—
Price / book3.19
EV / revenue2.18
EV / EBITDA17.87
Gross margin39.49%
Operating margin11.99%
Profit margin9.00%
Return on equity13.27%
Return on assets5.84%
Debt / equity2.78
Current ratio1.86
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $1.52B | $1.30B | $1.14B | $1.07B | +16.9% |
| Operating revenue | $1.47B | $1.25B | $1.09B | $1.03B | +17.4% |
| Cost of revenue | $921.08M | $810.93M | $712.34M | $686.17M | +13.6% |
| Gross profit | $596.70M | $487.01M | $429.20M | $388.11M | +22.5% |
| Selling, general & admin | $46.23M | $43.18M | $41.52M | $40.98M | +7.1% |
| Total operating expense | $468.35M | $397.11M | $371.74M | $359.38M | +17.9% |
| Operating income | $128.35M | $89.89M | $57.46M | $28.73M | +42.8% |
| Net interest income | $3.47M | $5.97M | $8.06M | $4.57M | -41.8% |
| Pre-tax income | $162.43M | $136.41M | $88.74M | $27.23M | +19.1% |
| Tax provision | $39.83M | $34.32M | $23.45M | $7.25M | +16.0% |
| Net income | $120.02M | $101.93M | $66.80M | $22.45M | +17.7% |
| Net income to common | $120.02M | $101.93M | $66.80M | $22.45M | +17.7% |
| Basic EPS | 7.76 | 6.62 | 4.36 | 1.46 | +17.2% |
| Diluted EPS | 7.67 | 6.53 | 4.34 | 1.45 | +17.5% |
| EBIT | $168.80M | $140.54M | $89.06M | $27.79M | +20.1% |
| EBITDA | $213.72M | $182.53M | $131.10M | $68.28M | +17.1% |
| Basic shares | 15.47M | 15.39M | 15.31M | 15.41M | +0.5% |
| Diluted shares | 15.65M | 15.60M | 15.38M | 15.45M | +0.3% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $92.83M | $76.12M | $107.08M | $58.67M | +21.9% |
| Cash & short-term investments | $255.80M | $216.19M | $223.62M | $182.59M | +18.3% |
| Accounts receivable | $139.00M | $135.32M | $108.55M | $99.99M | +2.7% |
| Inventory | $7.79M | $9.04M | $7.39M | $7.09M | -13.8% |
| Total current assets | $461.82M | $424.41M | $406.24M | $353.93M | +8.8% |
| Property, plant & equipment | $721.58M | $763.46M | $587.53M | $627.05M | -5.5% |
| Goodwill & intangibles | $190.34M | $190.34M | $175.33M | $175.33M | 0.0% |
| Total assets | $1.53B | $1.52B | $1.31B | $1.28B | +0.1% |
| Total current liabilities | $253.63M | $234.80M | $214.48M | $197.89M | +8.0% |
| Current debt | $7.50M | $7.50M | — | — | 0.0% |
| Long-term debt | $32.50M | $129.50M | — | — | -74.9% |
| Total debt | $87.07M | $214.77M | $93.39M | $125.94M | -59.5% |
| Total liabilities | $451.90M | $541.27M | $400.32M | $397.94M | -16.5% |
| Retained earnings | $832.98M | $752.19M | $687.60M | $656.66M | +10.7% |
| Shareholder equity | $1.07B | $980.16M | $908.75M | $874.28M | +9.0% |
| Working capital | $208.19M | $189.61M | $191.76M | $156.04M | +9.8% |
| Net tangible assets | $878.43M | $789.82M | $733.42M | $698.94M | +11.2% |
| Shares issued | 15.54M | 15.45M | 15.35M | 15.36M | +0.6% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | $122.61M | $102.09M | $65.29M | $19.98M | +20.1% |
| Depreciation & amortisation | $44.92M | $41.98M | $42.03M | $40.49M | +7.0% |
| Stock-based compensation | $4.40M | $4.16M | $2.78M | $2.61M | +5.7% |
| Change in working capital | $33.40M | -$25.72M | $17.40M | -$73.70M | +229.9% |
| Operating cash flow | $185.08M | $107.30M | $111.22M | $8.74M | +72.5% |
| Capital expenditure | -$36.45M | -$27.60M | -$27.90M | -$30.20M | -32.1% |
| Investing cash flow | -$33.86M | -$236.69M | -$17.57M | -$5.98M | +85.7% |
| Share buybacks | -$14.73M | -$13.50M | -$2.48M | -$9.90M | -9.1% |
| Dividends paid | -$38.70M | -$36.96M | -$35.56M | -$34.60M | -4.7% |
| Financing cash flow | -$135.96M | $100.34M | -$42.55M | -$47.64M | -235.5% |
| Free cash flow | $148.63M | $79.70M | $83.31M | -$21.46M | +86.5% |
| End cash position | $112.19M | $96.92M | $125.97M | $74.86M | +15.7% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $408.02M | $381.82M | $386.51M | $382.66M | $374.91M | +6.9% |
| Operating revenue | $378.36M | $369.81M | $373.69M | $370.99M | $363.35M | +2.3% |
| Cost of revenue | $241.90M | $235.07M | $233.24M | $233.18M | $226.53M | +2.9% |
| Gross profit | $166.12M | $146.75M | $153.27M | $149.49M | $148.38M | +13.2% |
| Selling, general & admin | $11.54M | $11.64M | $12.19M | $11.35M | $11.33M | -0.9% |
| Total operating expense | $117.19M | $114.49M | $120.16M | $119.11M | $114.29M | +2.4% |
| Operating income | $48.94M | $32.25M | $33.12M | $30.38M | $34.09M | +51.7% |
| Net interest income | $2.22M | $1.92M | $1.64M | $1.22M | $595.00K | +15.4% |
| Pre-tax income | $54.01M | $44.81M | $32.13M | $54.41M | $32.17M | +20.5% |
| Tax provision | $13.47M | $8.71M | $6.94M | $13.40M | $8.05M | +54.6% |
| Net income | $40.32M | $35.86M | $24.85M | $39.24M | $23.72M | +12.4% |
| Net income to common | $40.32M | $35.86M | $24.85M | $39.24M | $23.72M | +12.4% |
| Basic EPS | 2.58 | 2.31 | 1.60 | 2.53 | 1.53 | +11.7% |
| Diluted EPS | 2.54 | 2.27 | 1.58 | 2.50 | 1.52 | +11.9% |
| EBIT | $54.02M | $45.08M | $32.95M | $55.87M | $34.16M | +19.8% |
| EBITDA | $65.19M | $56.70M | $44.72M | $67.02M | $45.18M | +15.0% |
| Basic shares | 15.62M | 15.54M | 15.50M | 15.48M | 15.46M | +0.5% |
| Diluted shares | 15.86M | 15.77M | 15.74M | 15.66M | 15.60M | +0.6% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|---|
| Cash & equivalents | $39.21M | $85.53M | $92.83M | $130.63M | $110.99M | — | -54.2% |
| Cash & short-term investments | $210.19M | $258.35M | $255.80M | $297.38M | $257.63M | — | -18.6% |
| Accounts receivable | $137.70M | $137.74M | $139.00M | $132.45M | $142.06M | — | -0.0% |
| Inventory | $8.54M | $9.15M | $7.79M | $7.84M | $7.89M | — | -6.7% |
| Total current assets | $439.60M | $465.58M | $461.82M | $493.52M | $463.23M | — | -5.6% |
| Property, plant & equipment | $758.42M | $711.61M | $721.58M | $730.99M | $740.28M | — | +6.6% |
| Goodwill & intangibles | $190.84M | $190.34M | $190.34M | $190.34M | $190.34M | — | +0.3% |
| Total assets | $1.54B | $1.52B | $1.53B | $1.57B | $1.56B | — | +0.8% |
| Total current liabilities | $236.11M | $250.82M | $253.63M | $282.36M | $268.75M | — | -5.9% |
| Current debt | — | — | $7.50M | $7.50M | $7.50M | $7.50M | — |
| Long-term debt | — | — | $32.50M | $65.63M | $102.50M | $126.50M | — |
| Total debt | $31.41M | $39.31M | $87.07M | $128.07M | $172.61M | — | -20.1% |
| Total liabilities | $408.87M | $427.48M | $451.90M | $513.91M | $536.84M | — | -4.4% |
| Retained earnings | $888.68M | $858.85M | $832.98M | $818.08M | $788.77M | — | +3.5% |
| Shareholder equity | $1.12B | $1.09B | $1.07B | $1.05B | $1.02B | — | +2.9% |
| Working capital | $203.49M | $214.75M | $208.19M | $211.16M | $194.48M | — | -5.2% |
| Net tangible assets | $931.46M | $900.61M | $878.43M | $862.64M | $831.56M | — | +3.4% |
| Shares issued | 15.66M | 15.61M | 15.54M | 15.52M | 15.50M | — | +0.3% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Net income | $40.54M | $36.10M | $25.19M | $41.01M | $24.11M | +12.3% |
| Depreciation & amortisation | $11.17M | $11.61M | $11.77M | $11.16M | $11.02M | -3.8% |
| Stock-based compensation | $1.99M | $1.28M | $900.00K | $1.24M | $1.23M | +55.2% |
| Change in working capital | -$10.24M | $19.71M | -$29.34M | $29.90M | $28.00M | -151.9% |
| Operating cash flow | $43.27M | $62.53M | $16.81M | $66.20M | $62.82M | -30.8% |
| Capital expenditure | -$12.53M | -$9.64M | -$10.40M | -$9.71M | -$10.20M | -29.9% |
| Investing cash flow | -$87.67M | -$13.89M | -$12.93M | $1.98M | -$15.58M | -531.3% |
| Share buybacks | -$7.24M | -$16.32M | -$5.16M | -$3.18M | -$4.66M | +55.6% |
| Dividends paid | -$9.99M | -$9.94M | -$9.93M | -$9.92M | -$9.43M | -0.5% |
| Financing cash flow | -$9.65M | -$54.50M | -$43.22M | -$47.00M | -$33.04M | +82.3% |
| Free cash flow | $30.74M | $52.89M | $6.41M | $56.49M | $52.62M | -41.9% |
| End cash position | $52.28M | $106.33M | $112.19M | $151.53M | $130.36M | -50.8% |
Options analytics
Put / call volume
1.00
Call-heavy session
Put / call open interest
—
Positioning, not flow
Max pain
200.00
-12.4% from spot
ATM implied vol
1.6%
Nearest strike to spot
Skew (10% OTM)
+10.9%
Puts bid over calls
Call volume
1
Contracts, this expiry
Put volume
1
Contracts, this expiry
Heaviest call OI
220.00
0 contracts
Heaviest put OI
200.00
0 contracts
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2021 | — | 6.80 | — |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | — | — | $0 | — |
| Next quarter | — | — | $0 | — |
| Current year | — | — | $0 | — |
| Next year | — | — | $0 | — |
Analyst targets & ownership
Mean target—
High target—
Low target—
Implied upside—
Analyst count—
ConsensusNONE
Strong buy / Buy— / —
Hold—
Sell / Strong sell— / —
Held by insiders18.83%
Held by institutions66.69%
Institutions holding349
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
225.31
+1.31% from price
SMA 20
225.13
+1.39% from price
SMA 50
224.23
+1.80% from price
SMA 100
213.68
+6.83% from price
SMA 200
185.70
+22.92% from price
EMA 12
225.66
+1.16% from price
EMA 26
224.62
+1.62% from price
EMA 50
221.77
+2.93% from price
RSI (14)
55.0
Neutral
MACD (12,26,9)
1.04
Hist 0.44
ATR (14)
5.87
2.57% of price
Realised vol 30D
22.1%
Annualised
Bollinger upper
230.22
20, 2σ
Bollinger lower
220.04
20, 2σ
50 / 200 cross
Golden
224.23 vs 185.70
Trend bias
Above 200
+22.92%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
0.25
Less volatile than market
Correlation to SPY
0.10
Largely independent
Realised vol 30D
22.1%
Annualised
Market vol 1Y
13.0%
SPY, annualised
Max drawdown 1Y
-10.1%
Peak to trough
Max drawdown 5Y
-34.4%
Peak to trough
ATR 14
5.87
2.57% of price
Beta (reported)
0.61
5Y monthly, from filing
Short interest
Shares short
683.17K
Prior 756.85K
Change vs prior
-9.7%
Shorts covering
% of float
5.38%
Normal
% of shares out
4.36%
Against total outstanding
Days to cover
7.4
Crowded exit
Float
12.71M
Freely tradeable shares
Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.
Dividends & splits
Forward rate$2.68 / yr
Forward yield1.17%
5-year avg yield2.34%
Payout ratio29.13%
Ex-dividend dateSep 30, 2026
Next pay dateOct 30, 2026
Last split—
Split date—
SEC filings
Corporate Changes & Voting Matters
8-K · 2026-08-11
Periodic Financial Reports
10-Q · 2026-08-06
Corporate Changes & Voting Matters
8-K · 2026-07-01
Corporate Changes & Voting Matters
8-K · 2026-05-27
Corporate Changes & Voting Matters
8-K · 2026-05-15
Corporate Changes & Voting Matters
8-K · 2026-05-13
Corporate Changes & Voting Matters
8-K · 2026-05-08
Periodic Financial Reports
10-Q · 2026-05-07
Headlines
National Healthcare Insider Sold Shares Worth $1,087,650, According to a Recent SEC Filing
MT Newswires · 13d ago
National Healthcare Insider Sold Shares Worth $609,669, According to a Recent SEC Filing
MT Newswires · 22d ago
National Healthcare Insider Sold Shares Worth $1,537,694, According to a Recent SEC Filing
MT Newswires · 22d ago
National Healthcare Insider Sold Shares Worth $1,593,000, According to a Recent SEC Filing
MT Newswires · 34d ago
National Healthcare Insider Sold Shares Worth $355,620, According to a Recent SEC Filing
MT Newswires · 47d ago
Amid Legal Risks, This Company Is Still Rated a Buy
MarketBeat · 49d ago
NHC Reports Second Quarter 2026 Earnings
Business Wire · 61d ago
NHC Announces Common Dividend
Business Wire · 61d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.